Skip to content
PoliticalRepoPoliticalRepo

Person

Official portrait of Rep. Wilson, Joe [R-SC-2]

Rep. Wilson, Joe [R-SC-2]

United States · Official source

Records

5,131 records where Rep. Wilson, Joe [R-SC-2] is listed as a sponsor, author, or other actor. Search with topics and years

Bill· HRH.R. 8817 (119th)referred

FORTIFY Act

United States · United States Congress · 14 May 2026

Bill· HRH.R. 8665 (119th)referred

Allied Defense Sales Act

United States · United States Congress · 4 May 2026

Allied Defense Sales Act This bill directs the Department of State to implement a strategy to encourage foreign entities to participate in a multinational military procurement process. The State Department must also periodically report on the strategy and its implementation. Under the bill, this process involves the sale by the United States to a lead foreign nation of defense articles or services which are subsequently transferred to other qualifying countries. The strategy must incorporate existing efforts by the State Department to, for example, survey interest, identify countries and partners who could serve as lead purchase coordinators, review pathways for participation for countries that are ineligible for foreign military financing loans, identify challenges and solutions regarding compliance with the Arms Export Control Act, and identify opportunities to develop and promote exportable defense articles and services (including for purposes of supporting the trilateral security partnership between Australia, the United Kingdom, and the United States).

Bill· HRH.R. 8615 (119th)referred

FLEETS Now Act

United States · United States Congress · 30 April 2026

Bill· HRH.R. 8425 (119th)referred

Strengthening the Vaccines for Children Program Act of 2026

United States · United States Congress · 21 April 2026

Strengthening the Vaccines for Children Program Act of 2026 This bill expands vaccination programs and coverage for children under Medicaid and the Children's Health Insurance Program (CHIP). Specifically, the bill expands and otherwise modifies the Vaccines for Children Program, which provides free vaccinations to individuals 18 years of age or younger who are uninsured or underinsured (i.e., with limited or no insurance for vaccines), are eligible for Medicaid, or are American Indians or Alaskan Natives. The bill expands the program to include children enrolled in CHIP. The Government Accountability Office must report on the related effects of the bill's changes. The bill also temporarily requires payments under Medicaid and CHIP for vaccine administration and counseling services for children to be made at a rate that is no less than the rate under Medicare for equivalent services. It also increases the Federal Medical Assistance Percentage (i.e., federal matching rate) for states that conduct culturally appropriate outreach regarding the benefits of vaccinations for children.

Bill· HRH.R. 8205 (119th)open

Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026

United States · United States Congress · 6 April 2026

Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026 This bill reauthorizes through FY2031 and revises programs that support research and development of drugs and other therapies to address amyotrophic lateral sclerosis (also known as ALS or Lou Gehrig's disease) and other neurodegenerative diseases. The bill reauthorizes grants from the National Institutes of Health (NIH) for scientific research on investigational drugs to prevent or treat ALS for individuals not otherwise eligible for clinical trials, grants from the Food and Drug Administration (FDA) for research and development of therapies to prevent and treat ALS and other neurodegenerative diseases, and a Public-Private Partnership including the FDA and NIH that supports development and regulatory review of treatments for neurodegenerative diseases.  Also, the NIH, in considering renewal of its grants, must assess available information on the safety and efficacy of the investigational drugs. It must also require grantees to promptly report serious and unexpected adverse events associated with their investigational drugs. Additionally, the FDA must publish a plan describing actions it will take over a five-year period to foster development of safe and effective drugs, and facilitate access to investigational drugs, that treat ALS and other rare neurodegenerative diseases. The FDA must also publish a report describing the actions it has taken under the plan.

Bill· HRH.R. 8106 (119th)referred

RESCUE Act

United States · United States Congress · 26 March 2026

Bill· HRH.R. 7931 (119th)referred

IDA Act of 2026

United States · United States Congress · 12 March 2026

Bill· HRH.R. 7871 (119th)referred

MVP Act

United States · United States Congress · 9 March 2026

Medicaid VBPs for Patients Act or the MVP Act This bill provides statutory authority for regulations that allow for the use of varying best price points under value-based purchasing arrangements for purposes of the Medicaid Drug Rebate Program. ( Value-based purchasing arrangements refer to arrangements in which the price of a drug is linked to clinical outcomes; such arrangements are particularly used for new high-cost treatments, such as gene therapies.) The Government Accountability Office must study the impact of value-based purchasing arrangements on federal health care programs, including with respect to the bill's changes. Additionally, the bill (1) exempts sales of drugs that are made under value-based purchasing arrangements from calculations of the manufacturer average sales price for purposes of payments under Medicare medical services, if the manufacturer reports multiple best prices under Medicaid in accordance with the bill's changes; and (2) requires the Centers for Medicare & Medicaid Services to issue guidance on how state Medicaid programs may cover drugs in inpatient settings via value-based purchasing arrangements.

Bill· HRH.R. 7668 (119th)referred

Countering China’s Control of the Caucasus Act

United States · United States Congress · 24 February 2026

Countering China’s Control of the Caucasus Act This bill requires the Department of State to submit a classified report to Congress that examines Russian and Chinese influence and intelligence activity in the country of Georgia. The State Department must also submit a strategy for enhancing bilateral ties with Georgia, a determination of the resources needed to enhance such ties, and whether the United States should continue to invest in its partnership with Georgia and in Georgian projects.

Bill· HRH.R. 7613 (119th)referred

ALERT Act

United States · United States Congress · 20 February 2026

Airspace Location and Enhanced Risk Transparency Act of 2026 or the ALERT Act This bill addresses aviation safety by increasing requirements for aircraft tracking and communication using Automatic Dependent Surveillance-Broadcast (ADS-B) technology and expanding oversight. As background, ADS-B for broadcasting (Out) and receiving (In) transmits information (e.g., location and weather) among aircraft and air traffic control (ATC). The bill requires the Department of Defense (DOD) and the Department of Transportation (DOT) to enter into an agreement regarding the use of collision prevention technologies on DOD aircraft. The agreement must require the use of ADS-B Out as the default practice for DOD helicopters operating in the national airspace, unless such use would affect operational security. For DOD helicopters that are carrying out special missions in the Washington, DC, metropolitan area and are exempt from ADS-B Out transmission requirements, DOD must coordinate with DOT to conduct a safety risk assessment and implement appropriate mitigations. By December 31, 2031, DOD aircraft (other than certain special mission aircraft) must be equipped with and operating integrated ADS-B In technology. With respect to civil aircraft, by December 31, 2031, the Federal Aviation Administration (FAA) must generally require aircraft that are currently required to be equipped with ADS-B Out to also be equipped with ADS-B In. Additionally, among other requirements, the FAA must establish time-on-position limits for supervisory ATC personnel; establish a process to timely notify parties involved in certain near-miss incidents; and evaluate and revise, as necessary, helicopter routes around Ronald Reagan Washington National Airport.

Bill· HRH.R. 7415 (119th)referred

HARM Act 2.0

United States · United States Congress · 9 February 2026

Bill· HRH.R. 7188 (119th)referred

MOLD Act

United States · United States Congress · 21 January 2026

Bill· HRH.R. 7156 (119th)referred

SCAM Act

United States · United States Congress · 20 January 2026

Bill· HRH.R. 7095 (119th)referred

Ending Importation of Laundered Russian Oil Act

United States · United States Congress · 15 January 2026

Ending Importation of Laundered Russian Oil Act This bill prohibits the importation of energy products that were produced at any refinery that uses crude oil originating in Russia. Current law prohibits the importation of Russian products that are classified under Chapter 27 of the Harmonized Tariff Schedule of the United States (which includes mineral fuels, mineral oils and products of their distillation, bituminous substances, and mineral waxes) unless the President terminates the prohibition after meeting certain requirements. The bill extends this prohibition and the termination provisions to products that were produced at any refinery that uses crude oil originating in Russia. Under the termination provisions, the President may terminate this prohibition, subject to congressional disapproval, if the President certifies that Russia (1) has reached an agreement with Ukraine to withdraw Russian forces and cease military hostilities in Ukraine, (2) poses no immediate military threat of aggression to any North Atlantic Treaty Organization member, and (3) recognizes the right of the Ukrainian people to independently and freely choose their own government.

Bill· HRH.R. 7003 (119th)reported

BIS STRENGTH Act

United States · United States Congress · 9 January 2026

Bill· HRH.R. 6940 (119th)referred

Hope Heals Act of 2026

United States · United States Congress · 6 January 2026

Bill· HRH.R. 6857 (119th)referred

Protecting Students on Campus Act of 2025

United States · United States Congress · 18 December 2025

Protecting Students on Campus Act of 2025 This bill requires the Department of Education (ED) and institutions of higher education (IHEs) participating in federal student aid programs to distribute information on how to report alleged violations of civil rights under Title VI of the Civil Rights Act of 1964. (Title VI of the Civil Rights Act of 1964 prohibits discrimination based on race, color, or national origin in federally funded programs or activities.) Specifically, the bill requires ED's Office for Civil Rights (OCR) to conduct a public awareness campaign regarding the rights of individuals under Title VI. This campaign must be updated annually and distributed to IHEs. The bill requires an IHE to post a link on its website on how to file a Title VI complaint with OCR. Additionally, the IHE must annually post the materials from OCR's public awareness campaign. The information must be posted in high-traffic public places on campus (e.g., student centers) and high-traffic websites (e.g., the website for student services).  OCR must give monthly congressional briefings on (1) the number of complaints filed with OCR, (2) how OCR plans to address those complaints and the investigations opened in response to those complaints, and (3) how long those complaints remain open. The bill also requires annual reporting by IHEs on discrimination complaints. Further, the bill directs ED's Office of Inspector General to audit and study discrimination complaints.

Bill· HRH.R. 6766 (119th)referred

Essential Caregivers Act of 2025

United States · United States Congress · 16 December 2025

Essential Caregivers Act of 2025   This bill prohibits certain health care facilities from limiting the access of essential caregivers to residents of those facilities, including during designated emergency periods.   Specifically, the bill generally prohibits Medicare skilled nursing facilities, Medicaid nursing facilities, Medicaid intermediate care facilities, and associated inpatient rehabilitation facilities from restricting the access of essential caregivers to residents of the facilities, including during emergency periods in which visitation rights are otherwise restricted. During emergency periods, facilities may restrict access for an initial period of up to seven days and for one additional maximum seven-day period (if the additional period is approved by the state health department). Facilities may restrict access for a total of 7 days (or 14 days with the approval of the state health department) during an emergency period. Essential caregivers must agree to comply with any safety protocols set by the facility, which may be no more stringent for caregivers compared to those for staff. Caregivers who fail to comply with these requirements may be denied access, subject to an appeals process.